Navigation Links
AbbVie Reports Second-Quarter 2014 Financial Results
Date:7/25/2014

an the third quarter driven by product mix, particularly an increase in lower-margin Synagis sales. Q)How will investment in SG&A impact AbbVie's second-half 2014 results, particularly in light of the anticipated HCV approval and launch?A)

As noted on our fourth-quarter earnings conference call in January, we are forecasting a higher level of SG&A expense in 2014 compared to 2013, driven primarily by investments we are making for the upcoming launch of our HCV regimen in the U.S. and Europe.  For the third quarter, we expect a modest sequential increase in absolute SG&A expense from the second quarter.  For the fourth quarter, given the proximity to the U.S. HCV launch, we'd expect a more meaningful sequential increase in absolute SG&A expense from the third-quarter level.  This has been reflected in our recently-increased adjusted earnings-per-share guidance.Q)What level of R&D spend do you expect in second-half 2014?A)

We currently have a significant number of Phase 3 programs in active development including exciting opportunities in oncology, HCV, immunology and other areas that warrant investment.  As a result, we expect R&D expense to be above 16 percent of sales for the full-year 2014, reflecting a meaningful increase in R&D spending over the prior year.  For the third quarter, we expect a sequential increase in absolute R&D investment from the second-quarter level.  For the fourth quarter, we are forecasting a more modest sequential increase from the third-quarter level.  This has been reflected in our recently-increased adjusted earnings-per-share guidance.Marketed Product Performance QuestionsQ)What factors impacted HUMIRA performance in second-quarter 2014?A)

In the United States, HUMIRA sales increased 35.6 percent, driven by continued market expansion, share gains, and particularly strong growth in gastroenterology.  Second quarter wholesaler inventory leve
'/>"/>

SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. AbbVie to Host Second-Quarter Earnings Conference Call
2. AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
3. AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
4. AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
5. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
6. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
7. AbbVie Reports Third-Quarter 2013 Financial Results
8. AbbVie Named a Science Top Employer
9. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
11. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ... March 31, 2015, as well as general business updates. ... call will be held. Key Highlights ... 2015 increased to $206 million from $119 million for ... IMBRUVICA ® (ibrutinib) net product revenue of $247 ...
(Date:5/1/2015)... 2015  Misonix, Inc. (NASDAQ: MSON ), ... and markets innovative therapeutic ultrasonic products for spine ... laparoscopic surgery and other surgical applications, announced today ... third quarter fiscal year 2015 on Thursday, May ... call that same day, Thursday, May 7, 2015, ...
(Date:5/1/2015)... , May 1, 2015  Shares of Aerie ... of their value yesterday following the results of the ... therapy, Rhopressa.  Despite the trial failing to meet its ... positive results may come from future studies. ... company overview, current pipeline, financial review, analyst summary, valuation, ...
Breaking Medicine Technology:Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... MedClean Technologies (OTC Bulletin Board: ... for the treatment and disposal of medical waste ... media, today announced it has partnered with Triumvirate ... waste disposal, engineering and remediation. This agreement will ...
... DIEGO, Oct. 20, 2011 Sequenom, Inc. (NASDAQ: SQNM ... announced it will report financial results for the third quarter of ... 3, 2011. A conference call hosted by Harry F. ... management will take place on the same day at 5:00pm ET ...
Cached Medicine Technology:MedClean Technologies Partners With Triumvirate Environmental 2MedClean Technologies Partners With Triumvirate Environmental 3Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2
(Date:5/4/2015)... Peacock Alley knows we all feel how ... was the most beautiful woman I ever saw.” , ... prints and textures to remind her just how beautiful ... Robe to get you there. The beautiful Monet-inspired print has ... waist. It is available in small/medium or large/extra large. ...
(Date:5/3/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... . She has worked to enhance the well being of ... as a generalist in a hospital, followed by providing care for ... I worked with as an Adult Nurse Practitioner began wondering if ... coupled with the birth of my own children with my mentor ...
(Date:5/3/2015)... Indiana Fiber Network, LLC (IFN), the ... Services, Inc (BCS) has selected IFN as a fiber ... technology, service, and working relationship with IFN has been ... feel you get with IFN. I like dealing ... local decisions and operates as a local community business ...
(Date:5/3/2015)... May 03, 2015 It is not too late ... Aneurysm Walk in Memory of Lissa Anne Been in Arnold, ... this great family-friendly event to honor her loving memory. It has ... , Just having turned 37, Lissa suffered a brain ... on August 24, 2012. This event is designed to serve as ...
(Date:5/2/2015)... 02, 2015 “ ActOn ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... connected with organizations to make a difference. , In this ... few things that aren’t about money, which is why those ...
Breaking Medicine News(10 mins):Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... ... provides chiropractic patients with valuable information regarding the signs and symptoms of chiropractic stroke ... ... Michael A. Abelson, who has represented people severely injured by chiropractic neck manipulations, has ...
... ... ... May 7, 2010 - Accumed Research Associates recently announced their continued growth by providing ... clinical trials facility in Garden City, NY, now offers opportunities for all phases of ...
... On ... at Costa Rica and other countries in order to answer the question: Is Costa Rica ... ... has long been the investment darling of Central America when it comes to real estate ...
... ... Summit, conducted last fall by the Southern Illinois University Edwardsville School of Pharmacy, today ... pharmacists. The recommendations were release at the 29th Annual Scientific Meeting of the American ... ...
... ... specialist, citing a recent address by the U.S. Drug Control Policy Director, says government and ... interests will attempt to impede both. , ... Los Angeles (Vocus) May 6, 2010 -- Speaking to a coalition of anti-drug ...
... ... & Celebrity Centre Nashville mobilized Volunteer Ministers to staff shelters at Lipscomb University and ... flooded downtown Nashville, causing thousands of residents and visitors to evacuate homes and hotels. ... Nashville (Vocus) ...
Cached Medicine News:Health News:Chiropractic Stroke Website Launched To Aid Victims of Chiropractor Malpractice 2Health News:Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 2Health News:Is Costa Rica Still the Best Place in Central America for Purchasing Real Estate? 3Health News:SIUE Pain Summit Recommendations Announced Today 2Health News:SIUE Pain Summit Recommendations Announced Today 3Health News:Scientology Official Calls for Government-Community Cooperation to Attack Drug Abuse 2Health News:Church of Scientology Nashville Mobilizes Scientology Volunteer Ministers to Cope with Floods 2
... feature powerful, maintenance-free motors, and ... rotors for unparalleled application versatility. ... one: a high capacity general ... a high-speed centrifuge for separating ...
... Rotor has a standard 1.5ml rotor and 6 ... Easy operation (no switches to mess with). Simply ... the plastic tab to open. Starts and stops ... 2000 x g. Only five inches in diameter. ...
... Personal Micro Centrifuges MiniSpin and MiniSpin plus ... they are powerful enough so that each ... centrifuge for a wide range of molecular ... are available to meet your performance requirements. ...
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
Medicine Products: